JP2017527260A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017527260A5 JP2017527260A5 JP2016575345A JP2016575345A JP2017527260A5 JP 2017527260 A5 JP2017527260 A5 JP 2017527260A5 JP 2016575345 A JP2016575345 A JP 2016575345A JP 2016575345 A JP2016575345 A JP 2016575345A JP 2017527260 A5 JP2017527260 A5 JP 2017527260A5
- Authority
- JP
- Japan
- Prior art keywords
- tlr
- aptamer
- complex
- group
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP201430955. | 2014-06-24 | ||
| ES201430955A ES2555160B1 (es) | 2014-06-24 | 2014-06-24 | Aptámeros específicos de TLR-4 y usos de los mismos |
| PCT/EP2015/064277 WO2015197706A1 (en) | 2014-06-24 | 2015-06-24 | Aptamers specific for tlr-4 and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020082070A Division JP2020127422A (ja) | 2014-06-24 | 2020-05-07 | Ｔｌｒ−４特異的アプタマーおよびそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017527260A JP2017527260A (ja) | 2017-09-21 |
| JP2017527260A5 true JP2017527260A5 (enExample) | 2018-08-02 |
| JP6959738B2 JP6959738B2 (ja) | 2021-11-05 |
Family
ID=53496661
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016575345A Active JP6959738B2 (ja) | 2014-06-24 | 2015-06-24 | Ｔｌｒ−４特異的アプタマーおよびそれらの使用 |
| JP2020082070A Pending JP2020127422A (ja) | 2014-06-24 | 2020-05-07 | Ｔｌｒ−４特異的アプタマーおよびそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020082070A Pending JP2020127422A (ja) | 2014-06-24 | 2020-05-07 | Ｔｌｒ−４特異的アプタマーおよびそれらの使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US10196642B2 (enExample) |
| EP (1) | EP3161139B1 (enExample) |
| JP (2) | JP6959738B2 (enExample) |
| KR (1) | KR102454682B1 (enExample) |
| CN (2) | CN112111495A (enExample) |
| AU (1) | AU2015279248B2 (enExample) |
| BR (1) | BR112016030172B1 (enExample) |
| CA (1) | CA2953020C (enExample) |
| DK (1) | DK3161139T3 (enExample) |
| ES (2) | ES2555160B1 (enExample) |
| MA (1) | MA40283A (enExample) |
| MX (1) | MX387405B (enExample) |
| PL (1) | PL3161139T3 (enExample) |
| PT (1) | PT3161139T (enExample) |
| RU (1) | RU2709718C9 (enExample) |
| SI (1) | SI3161139T1 (enExample) |
| WO (1) | WO2015197706A1 (enExample) |
| ZA (1) | ZA201700363B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015155178A1 (en) * | 2014-04-07 | 2015-10-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New method for producing outer membrane vesicles |
| ES2555160B1 (es) * | 2014-06-24 | 2016-10-25 | Aptus Biotech, S.L. | Aptámeros específicos de TLR-4 y usos de los mismos |
| CA3030974A1 (en) | 2016-07-15 | 2018-01-18 | President And Fellows Of Harvard College | Glycolipid compositions and methods of use |
| EP3494994A1 (en) * | 2017-12-07 | 2019-06-12 | Universität zu Köln | Combinations of ripk1- and ikk-inhibitors for the prevention or treatment of immune diseases |
| IL280880B2 (en) | 2018-08-27 | 2025-04-01 | Regeneron Pharma | Using Raman Spectroscopy in Downstream Purification |
| AU2019347774A1 (en) | 2018-09-28 | 2021-03-25 | Nutcracker Therapeutics, Inc. | Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery |
| CN113423833B (zh) * | 2018-09-28 | 2024-09-17 | 奥曼尼提纳米有限公司 | 用于选择功能性适体的方法和组合物 |
| WO2020069569A1 (en) | 2018-10-02 | 2020-04-09 | WearOptimo Pty Ltd | Actuator system |
| US20210338158A1 (en) | 2018-10-02 | 2021-11-04 | WearOptimo Pty Ltd | Measurement system |
| US20220233572A1 (en) * | 2019-05-16 | 2022-07-28 | Aptatargets, S.L. | Treatment of tlr-4 mediated diseases and conditions with aptamers targeting tlr-4 |
| CN111474336B (zh) * | 2020-03-21 | 2023-07-28 | 南昌大学 | 一种铁氰化镍纳米粒化学发光适体传感器的制备方法及基于其检测8-OhdG的方法 |
| WO2021257494A1 (en) * | 2020-06-15 | 2021-12-23 | President And Fellows Of Harvard College | Methods for modulating tlr4 signaling |
| CN114152599B (zh) * | 2021-12-01 | 2023-10-13 | 中国农业大学 | 一种基于双劈裂功能核酸变构的孔雀石绿生物传感器 |
| CN114836425A (zh) * | 2022-02-25 | 2022-08-02 | 温州医科大学附属眼视光医院 | 检测小胶质细胞的核酸适体及应用 |
| WO2024146930A1 (en) | 2023-01-05 | 2024-07-11 | Aptatargets, S.L. | Aptoll molecules for the treatment of ischemic stroke and intracranial hemorrhages |
| WO2024240750A1 (en) | 2023-05-22 | 2024-11-28 | Aptatargets, S.L. | New tlr-4 antagonist aptamers |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5194599A (en) | 1988-09-23 | 1993-03-16 | Gilead Sciences, Inc. | Hydrogen phosphonodithioate compositions |
| US5264562A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences, Inc. | Oligonucleotide analogs with novel linkages |
| JPH06505704A (ja) | 1990-09-20 | 1994-06-30 | ギリアド サイエンシズ，インコーポレイテッド | 改変ヌクレオシド間結合 |
| CA2400006A1 (en) * | 2000-02-03 | 2001-08-09 | Research Development Foundation | Signaling aptamers that transduce molecular recognition to a differential signal |
| CN101227922A (zh) * | 2005-05-06 | 2008-07-23 | 斯克里普斯研究学院 | 经由CD14和Toll样受体4信号传导途径调节细胞的组合物和方法 |
| US20060257411A1 (en) * | 2005-05-06 | 2006-11-16 | Bruce Beutler | Compositions and methods for modulating cells via CD14 and toll-like receptor 4 signaling pathway |
| EP1895842A4 (en) * | 2005-06-17 | 2009-06-03 | Univ Rochester | METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE MEMORY BY BLOCKING INTRAHEPATIC ERASURE OF ACTIVE T CELLS |
| FR2892730A1 (fr) * | 2005-10-28 | 2007-05-04 | Biomerieux Sa | Methode pour detecter la presence ou le risque de developper un cancer |
| US20090317802A1 (en) * | 2005-12-09 | 2009-12-24 | Bhatia Sangeeta N | Compositions and Methods to Monitor RNA Delivery to Cells |
| US9012410B2 (en) * | 2006-12-13 | 2015-04-21 | Case Western Reserve University | Method of treating intrauterine inflammation |
| MX2011004674A (es) * | 2008-11-04 | 2011-05-25 | Idera Pharmaceuticals Inc | Modulacion de la expresion del receptor 4 tipo larga distancia por oligonucleotidos antisentido. |
| WO2010060030A1 (en) | 2008-11-24 | 2010-05-27 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona | Tlr ligand-nucleic acid nanostructure as a novel immune modulatory agent and method of using the same |
| SG192961A1 (en) * | 2011-03-03 | 2013-09-30 | Quark Pharmaceuticals Inc | Compositions and methods for treating lung disease and injury |
| AU2012223366B2 (en) * | 2011-03-03 | 2017-02-23 | Quark Pharmaceuticals, Inc. | Oligonucleotide modulators of the toll-like receptor pathway |
| ES2555160B1 (es) * | 2014-06-24 | 2016-10-25 | Aptus Biotech, S.L. | Aptámeros específicos de TLR-4 y usos de los mismos |
-
2014
- 2014-06-24 ES ES201430955A patent/ES2555160B1/es not_active Expired - Fee Related
-
2015
- 2015-06-24 CN CN202010953057.9A patent/CN112111495A/zh active Pending
- 2015-06-24 RU RU2016152094A patent/RU2709718C9/ru active
- 2015-06-24 MA MA040283A patent/MA40283A/fr unknown
- 2015-06-24 BR BR112016030172-2A patent/BR112016030172B1/pt active IP Right Grant
- 2015-06-24 JP JP2016575345A patent/JP6959738B2/ja active Active
- 2015-06-24 CN CN201580034070.1A patent/CN106459980B/zh active Active
- 2015-06-24 AU AU2015279248A patent/AU2015279248B2/en active Active
- 2015-06-24 WO PCT/EP2015/064277 patent/WO2015197706A1/en not_active Ceased
- 2015-06-24 MX MX2016016992A patent/MX387405B/es unknown
- 2015-06-24 ES ES15732619T patent/ES2825106T3/es active Active
- 2015-06-24 US US15/322,021 patent/US10196642B2/en active Active
- 2015-06-24 EP EP15732619.0A patent/EP3161139B1/en active Active
- 2015-06-24 KR KR1020177001493A patent/KR102454682B1/ko active Active
- 2015-06-24 DK DK15732619.0T patent/DK3161139T3/da active
- 2015-06-24 CA CA2953020A patent/CA2953020C/en active Active
- 2015-06-24 PT PT157326190T patent/PT3161139T/pt unknown
- 2015-06-24 PL PL15732619T patent/PL3161139T3/pl unknown
- 2015-06-24 SI SI201531392T patent/SI3161139T1/sl unknown
-
2017
- 2017-01-17 ZA ZA2017/00363A patent/ZA201700363B/en unknown
-
2018
- 2018-12-14 US US16/220,726 patent/US10808252B2/en active Active
-
2020
- 2020-05-07 JP JP2020082070A patent/JP2020127422A/ja active Pending
- 2020-09-16 US US17/022,984 patent/US11591603B2/en active Active
-
2023
- 2023-01-19 US US18/156,936 patent/US20230279402A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017527260A5 (enExample) | ||
| RU2016152094A (ru) | Аптамеры, специфические в отношении tlr-4, и их применение | |
| Tan et al. | Exosomes as nano-theranostic delivery platforms for gene therapy | |
| Halder et al. | Candida albicans induces cross-kingdom miRNA trafficking in human monocytes to promote fungal growth | |
| Stanley | Biological nanoparticles and their influence on organisms | |
| JP6938154B2 (ja) | 未分化細胞が除去された分化誘導細胞集団、その利用及びその製造方法 | |
| CN107405377B (zh) | 外泌体的破坏方法、外泌体的破坏试剂盒及来自正常细胞的外泌体的分离方法 | |
| US10160973B2 (en) | Nucleic acid aptamers binding to vascular endothelial growth factor receptors | |
| Yamala et al. | Poly-N-acryloyl-(l-phenylalanine methyl ester) hollow core nanocapsules facilitate sustained delivery of immunomodulatory drugs and exhibit adjuvant properties | |
| JP2017536826A5 (enExample) | ||
| Rat et al. | BAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopy | |
| WO2021095842A1 (ja) | バーコード化された細胞外小胞のライブラリー | |
| Metifiot et al. | Anticancer molecule AS1411 exhibits low nanomolar antiviral activity against HIV-1 | |
| CN103205431A (zh) | 一种核酸适配体及其衍生物、核酸适配体的筛选方法及在检测人胆管癌细胞株中的应用 | |
| Salehi et al. | Milk-derived extracellular vesicles: biomedical applications, current challenges, and future perspectives | |
| EP3824088A1 (en) | Compositions and methods related to aptamer-based reversible cell selection | |
| TW201604281A (zh) | 用以標的黑色素瘤相關抗原a3胜肽之寡核苷酸適體及其用途 | |
| US20230313325A1 (en) | Methods for detection of pathogenic infections using red blood cell-containing patient samples | |
| Gu et al. | Exosomes biogenesis and potentials in disease diagnosis and drug delivery | |
| CN104946655A (zh) | 一种结核分枝杆菌标准株H37Rv的DNA适配子及其制备方法 | |
| KR101825012B1 (ko) | 혈관내피전구세포 특이적 압타머 및 이의 이용 | |
| CN108865979A (zh) | 壳聚糖硒在抑制F-2毒素所致猪子宫内膜上皮细胞ERβ基因表达降低方面的应用 | |
| Chaikhumwang et al. | A new cell-to-cell interaction model for epithelial microfold cell formation and the enhancing effect of epidermal growth factor | |
| CN102876681A (zh) | 一种用于靶向药物载体的核酸适体 | |
| US20220233638A1 (en) | Cell competition inhibitor |